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 Helicobacter pylori (H. pylori) is a Gram-negative, microaerophilic bacterium that 
selectively colonizes the stomachs of half the world’s human population. H. pylori is the 
etiological agent of several gastric diseases that include chronic gastritis and peptic 
ulcers.  Long-term chronic inflammation subsequently increases the risk for the 
development of mucosa-associated lymphoid tissue (MALT) lymphoma and gastric 
cancer 1, 2.  During a well-choreographed interaction between the bacteria and the host 
gastric epithelium, H. pylori infection initiates an immune response that leads to a 
massive infiltration of inflammatory cells 1.  An evolutionarily-conserved cellular 
mechanism, autophagy, functions as an innate defense lysosomal pathway in response 
to infection to degrade intracellular microorganisms attempting to establish a replicative 
niche in the host epithelial cell cytoplasm 3.  Unfortunately, H. pylori utilizes a novel 
escape mechanism to evade lysosomal destruction in host epithelial cells that 
subsequently supports chronic infection.  A study in this month’s issue of 
Gastroenterology identifies, for the first time, an autophagy gene as a candidate for host 
susceptibility to H. pylori infection and disease progression 4. 
 
The H. pylori vacuolating cytotoxin (VacA) 
Vacuolating cytotoxin (VacA) is an important virulence factor for H. pylori disease 
pathogenesis.  The VacA gene encodes a 96-kDa precursor protein that is secreted and 
cleaved into an 88-kDa mature protein and a 10.5-kDa passenger domain 1.  The 
mature 88-kDa toxin can undergo further proteolytic cleavage to yield the p33 and p50 
fragments which represent the VacA functional domains that are required for toxin 
activity 5.  The most well recognized effect of VacA intoxication of mammalian cells is 
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the induction of vacuolation 6.  The toxin generates the formation of membrane 
channels by being secreted as monomers that oligomerize at the host plasma 
membrane 6.  Glycosylphosphatidylinositol anchored proteins enriched early endosomal 
compartments or GEECs are involved in endocytosis of VacA 7.  VacA then traffics to 
lysosomal compartments where the toxin induces vacuolation via a mechanism 
dependent on GTPase Rab7 8, 9, dynamin 10 and syntaxin 7 11.  In addition to 
vacuolation, VacA intoxication has detrimental effects that include inhibition of T cell 
proliferation 12 and the induction of apoptosis 6, increased cellular permeability 8 and 
autophagy within gastric epithelial cells 3, 9.  Initial studies demonstrated that H. pylori 
invades gastric epithelial cells and resides within vacuoles 13.  Later experiments then 
showed that these vacuoles were associated with the autophagy pathway and attributed 
to bacterial intracellular survival of H. pylori within gastric epithelial cells 3, 9. 
 
Autophagy in response to H. pylori VacA and persistent bacterial infection 
 In recent years autophagy has been recognized as being of central importance 
for the maintenance of cell homeostasis and survival but also for the regulation of 
inflammation and for bacterial defense at body surfaces 14.  Although H. pylori is 
generally considered to be a noninvasive pathogen, emerging evidence demonstrates 
that the bacteria also invade and replicate within autophagasomes of macrophages, 
dendritic and epithelial cells 3, 9, 12, 15.  In view of the observation that H. pylori infection 
induces autophagy within epithelial cells 3, 9, the question then remains as to how H. 
pylori are allowed to replicate within the autophagasome and evade lysosomal-induced 
degradation. 
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Raju and co-workers 4 recently reinforced that VacA, independent of the bacteria, 
alters the degradative capacity of the endocytic pathway.  Using gastric cancer epithelial 
AGS cells treated with culture supernatants from VacA-positive H. pylori the 
investigators show that although VacA intoxication induces autophagasome-lysosomal 
fusion cathepsin D levels were negligible 4.  Cathepsin D is a key hydrolase necessary 
for lysosomal-induced degradation.  Therefore, lack of cathepsin D would alternately 
disrupt autophagic degradative process and thus offer a plausible mechanism by which 
H. pylori replicate within autophagasomes. 
The investigators then extended the in vitro findings by studying the status of 
autophagy within human gastric biopsies collected from patients infected with H. pylori. 
The signaling adaptor p62 is a multidomainprotein implicated in the activation of the 
transcription factor NF-κB, apoptosis and autophagy. Dysfunctional autophagy leads to 
an accumulation of p62 that contributes directly to tumorigenesis 16.  Indeed, gastric 
tissue sections collected from patients infected with the toxigenic s1m1 VacA-producing 
H. pylori strain showed increased accumulation of p62 expression in the foveolar cells 
of the gastric epithelium 4.  However, the most interesting discovery that was made by 
Raju et al. 4 was that H. pylori infection was increased in individuals harboring a 
polymorphism in the ATG16L1 autophagy gene. 
 
The Crohn's variant of ATG16L1 as it relates to H. pylori susceptibility 
In autophagasomes, structures that need to be eliminated are sequestered into 
double-membrane-enclosed vesicles and delivered to lysosomes for final degradation.  
Autophagasome assembly involves activation of beclin-1 and conjugation of ATG12-
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ATG5 that is catalyzed by ATG7 and ATG10 17. The resulting ATG5-ATG12 conjugate 
is stabilized by a non-covalent complex with ATG16L1 that mediates, in addition to 
ATG7 and ATG3, the conversion of LC3B-I to LC3B-II by lipidation with 
phosphatidylethanolamine 17.  Interestingly, a variant of the ATG16L1 gene (rs2241880, 
causing amino acid substitution T300A) has been associated with the risk to develop 
Crohn’s disease 18, 19. Functional studies have shown that ATG16L1 and autophagy is 
critically involved in host defense against intracellular pathogens, such as Listeria 
monocytogenes or Salmonella typhimurium 20, 21.  Dysfunction of ATG16L1 has been 
implicated not only in defective autophagy and, consequently, bacterial handling, but 
also in altered gene/protein expression patterns in intestinal cells 20, 22. The presence of 
the Crohn’s disease associated T300A polymorphism within the ATG16L1 gene leads to 
the development of dysmorphic and dysfunctional Paneth cells in the intestine of 
Crohn’s disease patients 22.  
 In their recent manuscript in this month’s issue of Gastroenterology, Raju and co-
workers demonstrate that the T300A variant of ATG16L1, increases the susceptibility to 
H. pylori infection and partially prevents the VacA induced induction of autophagy. This 
indeed indicates that the process of autophagy has a protective role for bacterial 
invasion not only in the ileum or colon but also in the gastric mucosa.  Autophagy under 
this vies appears to be a very basic and broad innate defense mechanism not only to 
eliminate whole bacteria but also their toxins during infection.  However, the prolonged 
exposure to VacA leads to an impairment of autophagy and subsequently a failure to 
clear H. pylori infection.  Thus, chronic infection and subsequent accumulation of toxic 
material may aggravate the process. 
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 In conclusion, the study by Raju et al. 4 advances our current knowledge of VacA 
as an important pathogenic factor for H. pylori.  Figure 1 illustrates the process of 
increased H. pylori susceptibility and disease progression in response to the ATG16L1 
variant associated with the risk to develop Crohn’s disease.  During the initial stages of 
H. pylori infection VacA initiates autophagy.  The data presented by Raju et al 4 
collectively suggests that the bacterial load and level of VacA intoxication may be 
driving factors that determine the overall susceptibility to chronic infection and 
development of disease.  Based on this notion, during initial H. pylori exposure, if the 
bacterial load and VacA intoxication is low one would expect that host cell autophagy 
reduces the effects of the toxin and clears infection (Figure 1A).  However, the current 
study also elegantly demonstrates that in individuals carrying the ATG16L1 risk allele 
there is a reduced autophagic response.  Therefore, levels of low bacterial load and 
VacA toxin become enhanced, subsequently increasing the susceptibility of infection 
and disease progression (Figure 1B).  Prolonged exposure of VacA intoxication, that 
would commonly be associated with chronic infection, then results in the disruption of 
the autophagic degradative process that further exacerbated bacterial infection and 
disease by promoting H. pylori intracellular survival (Figure 1B).  Therapeutic options for 
the treatment of not only Crohn’s disease patients but also H. pylori infection may arise from 
insights into how impaired autophagy can be restored under these conditions. 
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Figure Legend 
Figure 1:  A model for the process of increased H. pylori susceptibility and 
disease progression in response to ATG16L1 variants associated with Crohn’s 
disease.  (A) During initial H. pylori exposure, if the bacterial load and VacA intoxication 
is low host cell autophagy is effective in reducing the effects of the toxin and clearing 
the infection. (B) Individuals carrying the ATG16L1 risk allele have a reduced 
autophagic response.  Levels of bacterial load and VacA toxin become enhanced 
subsequently increasing the susceptibility of infection and disease progression.  
Prolonged exposure of VacA results in the disruption of the autophagic degradative 
process that further exacerbates bacterial infection and disease by promoting H. pylori 
intracellular survival. 
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